Sonnet BioTherapeutics (SONN) Revenue (2010 - 2025)
Sonnet BioTherapeutics (SONN) revenue from Jun 30, 2010 to Sep 30, 2025. The TTM Sonnet BioTherapeutics (SONN) revenue is $1M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Sonnet BioTherapeutics (SONN) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +4900.00% |
| 3 Years TTM | +41.90% |
| 10 Years TTM | -29.38% |
| All Time TTM | +5.28% |
Annual Revenue change of Sonnet BioTherapeutics (SONN)
| Year | Revenue | Change |
|---|---|---|
| 2025 | $1M | +4900.00% |
| 2024 | $20K | -86.67% |
| 2023 | $150K | -57.14% |
| 2022 | $350K | -27.08% |
| 2021 | $480K | N/A |
| 2020 | $0 | -100.00% |
| 2019 | $30M | -1.92% |
| 2018 | $31M | -25.83% |
| 2017 | $41M | -0.65% |
| 2016 | $42M | +17.96% |
| 2015 | $35M | +18.47% |
| 2014 | $30M | +261.70% |
| 2013 | $8.25M | +20.44% |
| 2012 | $6.85M | +362.84% |
| 2011 | $1.48M | +957.14% |
| 2010 | $140K | N/A |